These findings revealed that, compared with biomarkers such as CA-125, CA-199, CA-153, and CEA, APT exhibited superior diagnostic value and greater efficacy in distinguishing breast cancer from nonneoplastic breast lesions in patients with breast nodules. The gene discussed is CEACAM5; the disease is breast carcinoma.